🕵️ Avenue Therapeutics, Inc. ($ATXI)
SEC insider & ownership activity, last 12 months · CIK 1644963 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. Fortress Biotech, Inc. added 10.3% → 13.4%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 13.4% | 13D | Jan 2, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Feb 18, 2026 | filing ↗ |
| Other events (8.01) | Feb 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 18, 2026 | filing ↗ |
| Shareholder vote (5.07) | Dec 30, 2025 | filing ↗ |
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 (5.08) | Nov 14, 2025 | filing ↗ |
| Other events (8.01) | Nov 14, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 5, 2025 | filing ↗ |
| Other events (8.01) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |